查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941426

子宮內膜異位症治療市場規模、佔有率和趨勢分析報告：按治療類型、藥物類別、給藥途徑、分銷管道、地區和細分市場預測，2026-2033年

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, Drug Class, Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

子宮內膜異位症治療市場概況

2025年全球子宮內膜異位症治療市場規模估計為19.7億美元，預計2033年將達到46.8億美元。

預計從 2026 年到 2033 年，該市場將以 11.28% 的複合年成長率成長。疾病負擔加重、疾病意識提高以及強大的產品平臺是推動市場成長的關鍵因素。

世界衛生組織（世衛組織）的數據顯示，全球約有10%的育齡婦女和女孩患有子宮內膜異位症。根據美國國家醫學圖書館2023年2月的報告，光是在印度，估計就有4,200萬名女性受到疾病的影響。這些令人震驚的數據凸顯了開發先進治療方案的迫切需求，同時也顯示子宮內膜異位症治療市場蘊藏著巨大的發展機會。

製藥公司正積極應對日益加重的疾病負擔，推出旨在改善患者預後的新治療方法。例如，2022年8月，輝瑞和Myovant Sciences宣布，其口服藥物MYFEMBREE獲得美國FDA核准，用於緩解閉經女性子宮內膜異位症引起的中度至重度疼痛。這項進展標誌著在滿足疾病患者未被滿足的需求方面邁出了重要一步。

公共衛生部門和非營利組織組織的宣傳宣傳活動也扮演著重要角色。政府對女性健康的支持以及子宮內膜異位症的具體診療指南也有助於提高公眾意識。例如，2022年2月，歐洲人類生殖與健康研究學會（ESHRE）發布了一份全面的臨床實務指引。該指南提供了治療建議和診斷方法，作為疾病管理的最佳實踐，包括緩解疼痛和治療不孕症。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數與趨勢

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場趨勢與展望
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTEL 分析
  • 管道分析（第三階段）

4. 子宮內膜異位症治療市場－依治療類型分類的細分市場分析，2021-2033年

  • 子宮內膜異位症治療市場：依治療類型分類的差異分析
  • 子宮內膜異位症治療市場：按治療類型分類的估計和預測

5. 子宮內膜異位症治療市場－按藥物類別分類的細分市場分析，2021-2033年

  • 子宮內膜異位症治療市場：依藥物類別分析變化
  • 子宮內膜異位症治療市場：按藥物類別分類的估計和預測

6. 子宮內膜異位症治療市場－依給藥途徑分類的細分市場分析，2021-2033年

  • 子宮內膜異位症治療市場：依給藥途徑分類的差異分析
  • 子宮內膜異位症治療市場：按給藥途徑分類的估算和預測

7. 子宮內膜異位症治療市場－按分銷管道分類的細分市場分析，2021-2033年

  • 子宮內膜異位症治療市場：按分銷管道分析市場波動
  • 子宮內膜異位症治療市場：按分銷管道分類的估算和預測

第8章：子宮內膜異位症治療市場：區域估算與趨勢分析（按類型、藥物類別、給藥途徑和分銷管道分類）

  • 子宮內膜異位症治療市場：區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲（MEA）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 參與企業
  • Participants'Overviews
  • 財務業績
  • 產品基準測試
  • 企業市場分析
  • 公司簡介
    • Bayer Ag
    • Pfizer, Inc
    • Abbvie, Inc
    • Astrazeneca
    • Obseva Sa
    • Teva Pharmaceutical Industries
    • Zydus Healthcare Limited
    • Astellas Pharma, Inc.
    • Gedeon Richter Plc.
    • Takeda Pharmaceutical Company Limited
  • 策略規劃
    • 新產品發布
    • 獲得
    • 合夥
    • 合夥
    • 其他（臨床試驗、宣傳活動、法律、定價）

第10章 結論

Product Code: GVR-4-68040-005-5

Endometriosis Treatment Market Summary

The global endometriosis treatment market size was estimated at USD 1.97 billion in 2025 and is projected to reach USD 4.68 billion by 2033, growing at a CAGR of 11.28% from 2026 to 2033. The rising disease burden, increasing disease awareness, and robust product pipeline are among the major factors driving the market growth.

According to the World Health Organization (WHO), approximately 10% of reproductive-age women and girls worldwide suffer from endometriosis. In India alone, the disorder affects an estimated 42 million women, as reported by the National Library of Medicine in February 2023. These alarming statistics underscore the urgent need for advanced therapeutic solutions, highlighting the growing market opportunity for endometriosis treatments.

Pharmaceutical companies are actively addressing this rising disease burden by introducing novel therapies aimed at improving patient outcomes. For instance, in August 2022, Pfizer Inc. and Myovant Sciences announced the U.S. FDA approval of MYFEMBREE, an oral treatment specifically designed to alleviate moderate to severe pain associated with endometriosis in premenopausal women. This development represents a significant step forward in addressing the unmet medical needs of patients suffering from this condition.

Awareness campaigns organized by public health departments and non-profit organizations also play a crucial role. Government support for women's health and specific guidelines for endometriosis care further contribute to heightened awareness. For example, in February 2022, the European Society of Human Reproduction and Embryology (ESHRE) published comprehensive guidelines on care. These guidelines provide best practices for managing the condition, including treatment recommendations and diagnostic approaches to alleviate pain and address infertility caused by endometriosis.

Global Endometriosis Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endometriosis treatment market report on the basis of treatment type, drug class, route of administration, distribution channel, and region

  • Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pain Medication
  • Hormone Therapy
  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • NSAIDs
  • Oral Contraceptive
  • Gonadotropin Releasing Hormone
  • Others
  • Route Of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
  • 1.2 Market Definitions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Objectives
    • 1.3.1 Objective - 1
    • 1.3.2 Objective - 2
    • 1.3.3 Objective - 3
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details Of Primary Research
  • 1.6 Information Or Data Analysis
    • 1.6.1 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country Wise Market Estimation Using Bottom-up Approach
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Treatment Type And Drug Class Segment Snapshot
  • 2.3 Route Of Administration And Distribution Channel Segment Snapshots
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables And Trends

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/ancillary Market Outloosk
  • 3.2 Market Trends & Outlook
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising Disease Burden
      • 3.3.1.2 Growing Awareness Toward The Disease
      • 3.3.1.3 Increasing Funding For Research And Development
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Availability Of Over The Counter And Generic Drugs
  • 3.4 Business Environment Analysis
    • 3.4.1 Porter's Five Forces Analysis
    • 3.4.2 Pestel Analysis
  • 3.5 Pipeline Analysis (Phase 3)

Chapter 4 Endometriosis Treatment Market- Segment Analysis, By Treatment Type, 2021 - 2033 (USD Million)

  • 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
  • 4.2 Endometriosis Treatment Market Estimates & Forecast, By Treatment Type (USD Million)
    • 4.2.1 Pain Medication
    • 4.2.2 Hormone Therapy

Chapter 5 Endometriosis Treatment Market- Segment Analysis, By Drug Class, 2021 - 2033 (USD Million)

  • 5.1 Endometriosis Treatment Market: Drug Class Movement Analysis
  • 5.2 Endometriosis Treatment Market Estimates & Forecast, By Drug Class (USD Million)
    • 5.2.1 Nsaids
    • 5.2.2 Oral Contraceptives
    • 5.2.3 Gonadotropin-releasing Hormone
    • 5.2.4 Others

Chapter 6 Endometriosis Treatment Market- Segment Analysis, By Route Of Administration, 2021 - 2033 (USD Million)

  • 6.1 Endometriosis Treatment Market: Route Of Administration Movement Analysis
  • 6.2 Endometriosis Treatment Market Estimates & Forecast, By Route Of Administration (USD Million)
    • 6.2.1 Oral
    • 6.2.2 Injectable
    • 6.2.3 Others

Chapter 7 Endometriosis Treatment Market- Segment Analysis, By Distribution Channel, 2021 - 2033 (USD Million)

  • 7.1 Endometriosis Treatment Market: Distribution Channel Movement Analysis
  • 7.2 Endometriosis Treatment Market Estimates & Forecast, By Distribution Channel (USD Million)
    • 7.2.1 Hospital Pharmacies
    • 7.2.2 Retail Pharmacies
    • 7.2.3 Others

Chapter 8 Endometriosis Treatment Market: Regional Estimates And Trend Analysis By Type, Drug Class, Route Of Administration, And Distribution Channel

  • 8.1 Endometriosis Treatment Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.2.2.3 Competitive/market Scenario
      • 8.2.2.4 Regulatory Framework
      • 8.2.2.5 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Canada Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.2.3.3 Competitive/market Scenario
      • 8.2.3.4 Regulatory Framework
      • 8.2.3.5 Reimbursement Scenario
    • 8.2.4 Mexico
      • 8.2.4.1 Key Country Dynamics
      • 8.2.4.2 Mexico Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.2.4.3 Competitive/market Scenario
      • 8.2.4.4 Regulatory Framework
      • 8.2.4.5 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 UK Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.2.3 Competitive/market Scenario
      • 8.3.2.4 Regulatory Framework
      • 8.3.2.5 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.3.3 Competitive/market Scenario
      • 8.3.3.4 Regulatory Framework
      • 8.3.3.5 Reimbursement Scenario
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.4.3 Competitive/market Scenario
      • 8.3.4.4 Regulatory Framework
      • 8.3.4.5 Reimbursement Scenario
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Italy Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.5.3 Competitive/market Scenario
      • 8.3.5.4 Regulatory Framework
      • 8.3.5.5 Reimbursement Scenario
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.6.3 Competitive/market Scenario
      • 8.3.6.4 Regulatory Framework
      • 8.3.6.5 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Influenza Vaccine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.7.3 Competitive/market Scenario
      • 8.3.7.4 Regulatory Framework
      • 8.3.7.5 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.8.3 Competitive/market Scenario
      • 8.3.8.4 Regulatory Framework
      • 8.3.8.5 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.3.9.3 Competitive/market Scenario
      • 8.3.9.4 Regulatory Framework
      • 8.3.9.5 Reimbursement Scenario
    • 8.3.10 Rest Of Europe Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.2.3 Competitive/market Scenario
      • 8.4.2.4 Regulatory Framework
      • 8.4.2.5 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.3.3 Competitive/market Scenario
      • 8.4.3.4 Regulatory Framework
      • 8.4.3.5 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.4.3 Competitive/market Scenario
      • 8.4.4.4 Regulatory Framework
      • 8.4.4.5 Reimbursement Scenario
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.5.3 Competitive/market Scenario
      • 8.4.5.4 Regulatory Framework
      • 8.4.5.5 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 Thailand Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.6.3 Competitive/market Scenario
      • 8.4.6.4 Regulatory Framework
      • 8.4.6.5 Reimbursement Scenario
    • 8.4.7 South Korea
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 South Korea Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.7.3 Competitive/market Scenario
      • 8.4.7.4 Regulatory Framework
      • 8.4.7.5 Reimbursement Scenario
    • 8.4.8 Rest Of Asia Pacific Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.2.3 Competitive/market Scenario
      • 8.5.2.4 Regulatory Framework
      • 8.5.2.5 Reimbursement Scenario
    • 8.5.3 Argentina
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Argentina Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.3.3 Competitive/market Scenario
      • 8.5.3.4 Regulatory Framework
      • 8.5.3.5 Reimbursement Scenario
    • 8.5.4 Rest Of Latin America Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6 Middle East & Africa (Mea)
    • 8.6.1 Mea Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.2.3 Competitive/market Scenario
      • 8.6.2.4 Regulatory Framework
      • 8.6.2.5 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.3.3 Competitive/market Scenario
      • 8.6.3.4 Regulatory Framework
      • 8.6.3.5 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.4.3 Competitive/market Scenario
      • 8.6.4.4 Regulatory Framework
      • 8.6.4.5 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.5.3 Competitive/market Scenario
      • 8.6.5.4 Regulatory Framework
      • 8.6.5.5 Reimbursement Scenario
      • 8.6.5.6 Rest Of Mea Endometriosis Treatment Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Participant Categorization
  • 9.2 Participants' Overviews
  • 9.3 Financial Performance
  • 9.4 Product Benchmarking
  • 9.5 Company Market Position Analysis
  • 9.6 Company Profiles
    • 9.6.1 Bayer Ag
      • 9.6.1.1 Company Overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product Benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Pfizer, Inc
      • 9.6.2.1 Company Overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product Benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 Abbvie, Inc
      • 9.6.3.1 Company Overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product Benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 Astrazeneca
      • 9.6.4.1 Company Overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product Benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 Obseva Sa
      • 9.6.5.1 Company Overview
      • 9.6.5.2 Financial Performance
      • 9.6.5.3 Product Benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Teva Pharmaceutical Industries
      • 9.6.6.1 Company Overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product Benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 Zydus Healthcare Limited
      • 9.6.7.1 Company Overview
      • 9.6.7.2 Financial Performance
      • 9.6.7.3 Product Benchmarking
      • 9.6.7.4 Strategic Initiatives
    • 9.6.8 Astellas Pharma, Inc.
      • 9.6.8.1 Company Overview
      • 9.6.8.2 Financial Performance
      • 9.6.8.3 Product Benchmarking
      • 9.6.8.4 Strategic Initiatives
    • 9.6.9 Gedeon Richter Plc.
      • 9.6.9.1 Company Overview
      • 9.6.9.2 Financial Performance
      • 9.6.9.3 Product Benchmarking
      • 9.6.9.4 Strategic Initiatives
    • 9.6.10 Takeda Pharmaceutical Company Limited
      • 9.6.10.1 Company Overview
      • 9.6.10.2 Financial Performance
      • 9.6.10.3 Product Benchmarking
      • 9.6.10.4 Strategic Initiatives
  • 9.7 Strategy Mapping
    • 9.7.1 New Product Launches
    • 9.7.2 Acquisition
    • 9.7.3 Collaborations
    • 9.7.4 Partnerships
    • 9.7.5 Others (Clinical Trials, Campaign, Legal, And Pricing)

Chapter 10 Conclusion

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Endometriosis Treatment Market, By Region, 2021 - 2033 (USD Million)
  • Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 9 Global Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 10 North America Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 12 North America Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 23 Mexico Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 24 Mexico Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 25 Mexico Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 26 Mexico Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 27 Mexico Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 28 Europe Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 29 Europe Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 30 Europe Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 31 Europe Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 32 Europe Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 33 Germany Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 34 Germany Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 35 Germany Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 36 Germany Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 37 U.K. Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 38 U.K. Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 39 U.K. Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 40 U.K. Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41 France Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 42 France Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 43 France Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 44 France Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 Italy Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 46 Italy Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 47 Italy Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 48 Italy Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 49 Spain Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 50 Spain Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 51 Spain Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 52 Spain Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 53 Denmark Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 54 Denmark Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 55 Denmark Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 56 Denmark Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 57 Sweden Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 58 Sweden Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 59 Sweden Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 60 Sweden Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Norway Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 62 Norway Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 63 Norway Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 64 Norway Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 65 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 66 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 67 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 68 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 69 Asia Pacific Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 71 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 72 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 73 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 74 Japan Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 75 Japan Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 76 Japan Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 77 Japan Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 78 China Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 79 China Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 80 China Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 81 China Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 82 India Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 83 India Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 84 India Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 85 India Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 South Korea Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 87 South Korea Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 88 South Korea Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 89 South Korea Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 90 Australia Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 91 Australia Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 92 Australia Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 93 Australia Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 94 Thailand Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 95 Thailand Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 96 Thailand Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 97 Thailand Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 98 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 99 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 100 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 101 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 102 Latin America Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 103 Latin America Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 104 Latin America Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 105 Latin America Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 106 Latin America Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 107 Brazil Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 108 Brazil Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 109 Brazil Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 110 Brazil Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 111 Mexico Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 112 Mexico Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 113 Mexico Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 114 Mexico Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 115 Argentina Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 116 Argentina Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 117 Argentina Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 118 Argentina Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 119 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 120 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 121 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 122 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 123 Middle East & Africa Endometriosis Treatment Market, By Country, 2021 - 2033 (USD Million)
  • Table 124 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 125 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 126 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 127 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 128 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 129 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 130 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 131 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 132 South Africa Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 133 South Africa Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 134 South Africa Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 135 South Africa Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 136 UAE Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 137 UAE Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 138 UAE Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 139 UAE Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 140 Kuwait Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 141 Kuwait Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 142 Kuwait Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 143 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 144 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2021 - 2033 (USD Million)
  • Table 145 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2021 - 2033 (USD Million)
  • Table 146 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 147 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 148 Key companies undergoing new product launches
  • Table 149 Key companies undergoing new acquisitions
  • Table 150 Key companies undergoing collaborations
  • Table 151 Key companies undergoing partnerships
  • Table 152 Key companies undergoing other strategies

List of Figures

  • Fig. 1 Endometriosis treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment type and drug class segment snapshot
  • Fig. 10 Route of administration and distribution channel Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Women's health market value, 2025 (USD Billion)
  • Fig. 13 Market trends & outlook
  • Fig. 14 Porter's five force analysis
  • Fig. 15 PESTEL analysis
  • Fig. 16 Endometriosis treatment market: Treatment type outlook and key takeaways
  • Fig. 17 Endometriosis treatment market: Treatment type movement analysis
  • Fig. 18 Pain medication market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Hormone therapy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Endometriosis treatment market: Drug class outlook and key takeaways
  • Fig. 21 Endometriosis treatment market: Drug class movement analysis
  • Fig. 22 NSAIDs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Oral contraceptives market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Gonadotropin-releasing hormone market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Endometriosis treatment market: Route of administration outlook and key takeaways
  • Fig. 27 Endometriosis treatment market: Route of administration movement analysis
  • Fig. 28 Oral market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Endometriosis treatment market: Distribution channel outlook and key takeaways
  • Fig. 32 Endometriosis treatment market: Distribution channel movement analysis
  • Fig. 33 Hospital pharmacies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Retail pharmacies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Endometriosis treatment market revenue, by region, 2024 & 2030, USD Million
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 U.S. endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Prevalence of endometriosis in the U.S. (2021 - 2033) in Million
  • Fig. 42 Key country dynamics
  • Fig. 43 Canada endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Prevalence of endometriosis in the Canada. (2021 - 2033) in Million
  • Fig. 45 Key country dynamics
  • Fig. 46 Mexico endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Prevalence of endometriosis in the Mexico. (2021 - 2033) in Million
  • Fig. 48 Europe endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Prevalence of endometriosis in the UK. (2021 - 2033) in Million
  • Fig. 52 Key country dynamics
  • Fig. 53 Germany endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Prevalence of endometriosis in the Germany. (2021 - 2033) in Million
  • Fig. 55 Key country dynamics
  • Fig. 56 France endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Prevalence of endometriosis in the France. (2021 - 2033) in Million
  • Fig. 58 Key country dynamics
  • Fig. 59 Italy endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Prevalence of endometriosis in the Italy. (2021 - 2033) in Million
  • Fig. 61 Key country dynamics
  • Fig. 62 Spain endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Prevalence of endometriosis in the Spain. (2021 - 2033) in Million
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Prevalence of endometriosis in the Denmark. (2021 - 2033) in Million
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Prevalence of endometriosis in the Sweden. (2021 - 2033) in Million
  • Fig. 70 Key country dynamics
  • Fig. 71 Norway endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Prevalence of endometriosis in the Norway. (2021 - 2033) in Million
  • Fig. 73 Rest of Europe endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Asia Pacific endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Prevalence of endometriosis in the Japan. (2021 - 2033) in Million
  • Fig. 78 Key country dynamics
  • Fig. 79 China endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Prevalence of endometriosis in the China. (2021 - 2033) in Million
  • Fig. 81 Key country dynamics
  • Fig. 82 India endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Prevalence of endometriosis in the India. (2021 - 2033) in Million
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 86 Prevalence of endometriosis in the Australia. (2021 - 2033) in Million
  • Fig. 87 Key country dynamics
  • Fig. 88 Thailand endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 89 Prevalence of endometriosis in the Thailand. (2021 - 2033) in Million
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 Prevalence of endometriosis in the South Korea. (2021 - 2033) in Million
  • Fig. 93 Rest of Asia Pacific endometriosis treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Latin America endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Brazil endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Prevalence of endometriosis in the Brazil. (2021 - 2033) in Million
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Prevalence of endometriosis in the Argentina. (2021 - 2033) in Million
  • Fig. 101 Rest of Latin America endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 MEA endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 South Africa endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Prevalence of endometriosis in the South Africa. (2021 - 2033) in Million
  • Fig. 106 Key country dynamics
  • Fig. 107 Saudi Arabia endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Prevalence of endometriosis in the Saudi Arabia. (2021 - 2033) in Million
  • Fig. 109 Key country dynamics
  • Fig. 110 UAE endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 111 Prevalence of endometriosis in the UAE. (2021 - 2033) in Million
  • Fig. 112 Key country dynamics
  • Fig. 113 Kuwait endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Prevalence of endometriosis in the Kuwait. (2021 - 2033) in Million
  • Fig. 115 Rest of MEA endometriosis treatment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 116 Company/competition categorization
  • Fig. 117 Company market position analysis, 2025
  • Fig. 118 Strategy mapping